C81.74

Clinical Causes: Genetic predispositions or family history of lymphoma Infections with Epstein-Barr virus (EBV) or other viruses Exposure to certain chemicals or pesticides Weakened immune system due to HIV/AIDS or immunosuppressive treatments Age and gender factors, with peak incidence in early adulthood and later in older age

Key Symptoms: Painless swelling of lymph nodes, especially in the armpits, neck, or above the collarbone Night sweats that may soak clothing or bedding Unexplained fever and chills Unintentional weight loss Fatigue and general malaise Itching skin without a rash Persistent cough or chest pain if the lymphoma affects mediastinal lymph nodes Shortness of breath or cough if lymph nodes press on the lungs or airways

Diagnosis Path: Diagnosing Hodgkin lymphoma of the axilla and upper limb involves several steps to confirm the presence of cancer and determine its extent. These include: - Physical examination focusing on lymph node swelling - Imaging tests such as CT scans or PET scans to identify affected areas - Tissue biopsy of the enlarged lymph nodes to detect Reed-Sternberg cells - Blood tests to assess overall health and organ function - Bone marrow biopsy if systemic spread is suspected The combination of these diagnostic tools helps in staging the disease, which guides treatment planning.

Treatment Protocols: Treating Hodgkin lymphoma typically involves therapy aimed at destroying cancer cells and preventing recurrence. The main treatment options include: - Chemotherapy: Use of drugs to kill cancer cells, often administered in cycles - Radiation therapy: Targeted high-energy rays to destroy lymphoma cells in specific areas - Immunotherapy: Treatments that help boost the body's immune response against lymphoma - Targeted therapy: Drugs designed to attack specific molecules involved in the growth of lymphoma cells - Stem cell transplant: For advanced cases or relapse, high-dose chemotherapy followed by stem cell transplant may be recommended The choice of treatment depends on the disease stage, patient health, and response to initial therapies. Regular follow-up is essential to monitor for remission or recurrence.